Send Enquiry

PRIMA
Injection
Packaging and packing Type
| 1
MRP :
₹429.45
PTR :
₹327.2
PTS :
₹294.48
Hospital use Read More
Composition
Send Enquiry
India’s Trusted Pharma Brand
100%
Genuine Products
Secure
Payments
24 x 7
Customer Support
About the product
By Vibcare Pharma · Updated 9 October 2026 · Based on product labels and standard drug references
Vibotaz 4.5 is an injection made by Vibcare Pharma and supplied from the Prima division. Each unit contains Piperacillin 4 gm and Tazobactam 0.5 gm as the two active ingredients. It belongs to the antibiotic and anti-infective (antibacterial) class of medicines and is packed as 1's.
Piperacillin works by stopping the formation of the bacterial cell wall, so susceptible bacteria are killed. Tazobactam has little action on bacteria by itself, but it blocks certain beta-lactamase enzymes that bacteria produce to destroy penicillins. By holding these enzymes in check, it allows Piperacillin to keep working against such organisms.
This injection is used for intra-abdominal infections, nosocomial pneumonia, skin and skin structure infections, female pelvic infections and community-acquired pneumonia in adults.
Given only by a doctor or nurse.
Common
Get medical help at once if you notice
Do not use
Ask a doctor first
Vibotaz 4.5 injection from Vibcare Pharma, used for bacterial infections of the abdomen, lungs, skin and pelvis. Main uses: intra-abdominal infections such as complicated appendicitis and peritonitis in adults and children 2 months of age and older; nosocomial (hospital-acquired) pneumonia in adults and children 2 months of age and older; skin and skin structure infections in adults; female pelvic infections in adults; community-acquired pneumonia in adults.
Common side effects of Vibotaz 4.5 Injection include diarrhoea; constipation; nausea; headache; trouble sleeping (insomnia); rash and itching. Get medical help at once if you notice severe allergic reactions including anaphylaxis (breathing difficulty, swelling, fall in blood pressure); the injection must be stopped if a reaction occurs; severe skin reactions such as Stevens-Johnson syndrome or toxic epidermal necrolysis; the injection must be stopped if a rash appears and gets worse; blood problems such as bleeding, low white cell count or neutropenia during prolonged therapy (blood tests are monitored), hemophagocytic lymphohistiocytosis (the injection must be stopped immediately if suspected) and rhabdomyolysis or muscle breakdown (the injection must be stopped and treatment started).
Vibotaz 4.5 Injection contains Piperacillin 4 g + Tazobactam 0.5 g. Vibotaz 4.5 Injection is given by a doctor or nurse, who decides the dose and how often it is given.
The MRP of Vibotaz 4.5 Injection is ₹429.45 for a pack of 1. For chemists and distributors, the PTR is ₹327.2 and the PTS is ₹294.48.
Vibotaz 4.5 Injection contains Piperacillin 4 g + Tazobactam 0.5 g. It comes in a pack of 1.
Piperacillin works by stopping the formation of the bacterial cell wall, so susceptible bacteria are killed. Tazobactam has little action on bacteria by itself, but it blocks certain beta-lactamase enzymes that bacteria produce to destroy penicillins. By holding these enzymes in check, it allows Piperacillin to keep working against such organisms.
Must not be used by patients with a history of allergic reactions to any penicillin, cephalosporin or beta-lactamase inhibitor. Check with a doctor first if there is kidney disease, a bleeding disorder, or if blood thinners or other strong medicines are being taken. Check with a doctor first if any rash appears or gets worse during treatment. Check with a doctor first during pregnancy and breastfeeding.
Vibotaz 4.5 Injection is a brand of Vibcare Pharma, sold through its Prima division. It is available for PCD pharma franchise and distribution in India; use the Send Enquiry or WhatsApp button on this page to ask about availability and terms.
Similar Products
Send Enquiry
Request a callback to get more information about becoming a PCD Franchise Owner